Impact of induced pluripotent stem cells on the study of central nervous system disease
- 27 January 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 21 (3) , 354-361
- https://doi.org/10.1016/j.gde.2011.01.008
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem CellsCell, 2010
- Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved IssuesCell, 2010
- Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acidMolecular and Cellular Neuroscience, 2010
- Pluripotent Stem Cells and Disease ModelingPublished by Elsevier ,2009
- Cell‐free production of transducible transcription factors for nuclear reprogrammingBiotechnology & Bioengineering, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- MECP2 promoter methylation and X chromosome inactivation in autismAutism Research, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivoBrain Research, 2007